Literature DB >> 3417360

Cigarette smoking, alcohol consumption and primary liver cancer: a case-control study in the USA.

H Yu1, R E Harris, G C Kabat, E L Wynder.   

Abstract

Cigarette smoking and alcohol consumption were examined as potential risk factors in a case-control study of primary liver cancer (PLC). A total of 165 PLC cases and 465 matched controls from several US hospitals were studied. A weak but statistically significant (p less than 0.05) dose-response relationship was observed between alcohol consumption and PLC in elderly females independent of other major risk factors (adjusted OR = 1.87 and 3.48 for 1-2 and greater than 3 drinks per day, respectively) and a similar trend was evident in elderly males. The risk for PLC was also elevated in elderly females who were current cigarette smokers (adjusted OR = 3.30). Our results suggest that alcohol consumption and cigarette smoking may have minor age- and sex-specific effects on the development of PLC, and underscore the need for further investigations to elucidate major PLC risk factors in US populations.

Entities:  

Mesh:

Year:  1988        PMID: 3417360     DOI: 10.1002/ijc.2910420304

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.

Authors:  Linda-L Wong; Whitney-M Limm; Naoky Tsai; Richard Severino
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Cigarette smoking and liver cancer among US veterans.

Authors:  A W Hsing; J K McLaughlin; Z Hrubec; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

3.  A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study.

Authors:  S Aricó; G Corrao; P Torchio; G Galatola; M Tabone; M Valenti; F Di Orio
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

4.  Clinical application of thioredoxin reductase as a novel biomarker in liver cancer.

Authors:  Xuping Wu; Qi Wang; Yousheng Lu; Jinye Zhang; Hanwei Yin; Yongxiang Yi
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

Review 5.  Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines.

Authors:  Ayman A Abdo; Mazen Hassanain; AbdulRahman AlJumah; Ashwaq Al Olayan; Faisal M Sanai; Hamad A Alsuhaibani; Huda Abdulkareem; Khalid Abdallah; Mohammad AlMuaikeel; Mohammad Al Saghier; Mohammad Babatin; Monther Kabbani; Shouki Bazarbashi; Peter Metrakos; Jordi Bruix
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.